art-painter-shutterstock-com
Art Painter / Shutterstock.com
1 April 2016Africa

GSK to widen access to medicines in world’s poorest countries

Pharmaceutical company GSK has adopted a new approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
12 February 2016   GSK has been fined more than £37 million by the UK government for “anti-competitive conduct” in relation to ‘pay for delay’ deals centring on anti-depressant drug Seroxat.
Big Pharma
17 March 2016   Pharmaceutical company GSK has announced to shareholders that its chief executive Sir Andrew Witty will be retiring from his role in 2017.

More on this story

Africa
12 February 2016   GSK has been fined more than £37 million by the UK government for “anti-competitive conduct” in relation to ‘pay for delay’ deals centring on anti-depressant drug Seroxat.
Big Pharma
17 March 2016   Pharmaceutical company GSK has announced to shareholders that its chief executive Sir Andrew Witty will be retiring from his role in 2017.

More on this story

Africa
12 February 2016   GSK has been fined more than £37 million by the UK government for “anti-competitive conduct” in relation to ‘pay for delay’ deals centring on anti-depressant drug Seroxat.
Big Pharma
17 March 2016   Pharmaceutical company GSK has announced to shareholders that its chief executive Sir Andrew Witty will be retiring from his role in 2017.